Janssen Pharmaceutica NV

We are part of the world’s largest healthcare company, Johnson & Johnson, and enjoy an international reputation for pharmaceutical innovation and quality. For instance, EPREX™ , a breakthrough in the treatment of anaemia, has helped hundreds of thousands of patients and achieved sales of more than US$3 billion. And RISPERDAL™ , an innovative medicine for schizophrenia, won the first-ever International Prix Galien for outstanding pharmaceutical achievement.